Pulmonary Phaeohyphomycosis Caused by Phaeoacremonium in a Kidney Transplant Recipient: Successful Treatment with Posaconazole

Table 2

Invasive and disseminated infections due to Phaeoacremonium species.

Number	Reference	Species	Age/sex	Underlying condition	Clinical disease	Treatment	Outcome
21	Heath et al., 1997 [23]	P. parasiticum	45/M	Liver transplant	Infective endocarditis, fungemia, and skin lesion	Amphotericin B, fluconazole	Died
22	Wang et al., 2005 [24]	P. inflatipes	18- month boy	Aplastic anemia	Fungemia	Amphotericin B	Died
23	Baddley et al., 2006 [9]	P. parasiticum	31/F	Aplastic anemia	Fungemia, skin lesions	Amphotericin B	Died
24	McNeil et al., 2011 [25]	P. parasiticum	24/M	Chronic granulomatous disease, end-stage kidney disease	Brain abscess	Amphotericin B, voriconazole, caspofungin	Died
25	To et al., 2012 [21]	P. parasiticum	26/M	Renal transplant	Cavitary lesion of lung	Voriconazole Caspofungin	Responded, but died
26	Shah et al., 2013 [26]	P. parasiticum	74/M	Lung transplant	Lung nodules of native lung	Caspofungin Voriconazole	Improved
27	Larbcharoensub et al., 2013 [27]	Scedosporium apiospermum and; P. parasiticum	49 y/o	Renal transplant	Multiple brain abscesses	Voriconazole	Improved
28	Present case	Phaeoacremonium species	49/F	Renal transplant	Lung nodules	Posaconazole	Improved